Vimarsana
Biggest News Aggregation in the World

Page 27 - Cell Proliferation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Proliferation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Proliferation Today - Breaking & Trending Today

[Full text] Sinomenine Inhibits the Growth of Ovarian Cancer Cells Through the Sup - Vimarsana News

[Full text] Sinomenine Inhibits the Growth of Ovarian Cancer Cells Through the Sup

CDK1, BUB1) play important roles in the progression of G2/M phase in the cell cycle. 30,31 Furthermore, real-time PCR analysis was used to verify the results of transcriptome sequencing and the results indicated that the expression trends of the top 18 ranked degree genes were consistent with those obtained by RNA-seq, suggesting that the RNA-seq data reliably reflected the gene expression alterations (Figure 4B). According to the RNA-seq and real-time PCR results, the expressions of cell cycle regulated genes, such as CDK1, PLK1, and BUB1, were significantly decreased after sinomenine tr...

Global Cell Proliferation Market Research Report 2021-2025 - Vimarsana News

Global Cell Proliferation Market Research Report 2021-2025

03/02/2021 - 09:33 Bharat Book Bureau Provides the Trending Market Research Report on “Global Cell Proliferation Market Research Report 2021-2025”under Life Sciences Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports. The Global Cell Proliferation Market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025. Cell Proliferation is a bimonthly open-access online-only scientific journal covering cell biology. In the...

Ascentage Pharma Released Preclinical Results of MDM2-p53 Inhibitor APG-115 in an Oral Presentation at WCLC 2020, Demonstrating Therapeutic Potential in STK11-Mutant Non-Small Cell Lung Cancer - Vimarsana News

Ascentage Pharma Released Preclinical Results of MDM2-p53 Inhibitor APG-115 in an Oral Presentation at WCLC 2020, Demonstrating Therapeutic Potential in STK11-Mutant Non-Small Cell Lung Cancer

Share this article Share this article SUZHOU, China and ROCKVILLE, Md., Feb. 2, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that the company recently released the results from a preclinical study of APG-115, a novel MDM2-p53 inhibitor being developed by Ascentage Pharma, in the treatment of non-small cell lung cancer (NSCLC) harboring STK11 mutations through an oral presentation on January 29, 2021, at the 2020 World Co...

Anti-emetic drug offers a promising approach to treat chronic myeloid leukemia - Vimarsana News

Anti-emetic drug offers a promising approach to treat chronic myeloid leukemia

Anti-emetic drug offers a promising approach to treat chronic myeloid leukemia Chronic myeloid leukemia (CML) results from a degeneration of the hematopoietic stem cells (leukemia stem cells), thereby leading to the uncontrolled formation of specific white blood cells, the so-called granulocytes. Research work at the Department of Medical Oncology at the Inselspital, Bern University Hospital and the University of Bern focused therefore on identifying the signaling pathways and control mechanisms of the leukemia stem cell. A promising approach is provided by working with MPR, an anti-emetic me...

[Full text] Plakophilin-2 Promotes Lung Adenocarcinoma Development via Enhancing F - Vimarsana News

[Full text] Plakophilin-2 Promotes Lung Adenocarcinoma Development via Enhancing F

1 1Medical Oncology Department of Thoracic Cancer (2), Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang 110042, Liaoning, People’s Republic of China; 2Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, Liaoning, People’s Republic of China Correspondence: Rui Ma Medical Oncology Department of Thoracic Cancer (2), Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang 110042, Liaoning, People’s Republic of China Background: Lung cancer is one of the most aggressive tumors with high incid...